ProMIS Neurosciences (PMN) Short Interest Ratio & Short Volume $1.08 -0.07 (-6.09%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ProMIS Neurosciences Short Interest DataProMIS Neurosciences (PMN) has a short interest of 137,800 shares, representing 0.60% of the float (the number of shares available for trading by the public). This marks a 7.66% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 73,398 shares to cover all short positions.Current Short Interest137,800 sharesPrevious Short Interest128,000 sharesChange Vs. Previous Month+7.66%Dollar Volume Sold Short$143,312.00Short Interest Ratio0.8 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares29,885,000 sharesFloat Size23,040,000 sharesShort Percent of Float0.60%Today's Trading Volume32,462 sharesAverage Trading Volume73,398 sharesToday's Volume Vs. Average44% Short Selling ProMIS Neurosciences? Sign up to receive the latest short interest report for ProMIS Neurosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPMN Short Interest Over TimePMN Days to Cover Over TimePMN Percentage of Float Shorted Over Time Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why ProMIS Neurosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024137,800 shares $143,312.00 +7.7%0.6%0.8 $1.04 9/30/2024128,000 shares $160,000.00 -12.0%0.6%0.8 $1.25 9/15/2024145,400 shares $178,842.00 +12.9%0.6%1 $1.23 8/31/2024128,800 shares $175,966.56 +14.5%0.6%0.9 $1.37 8/15/2024112,500 shares $137,812.50 +1.3%0.6%0.9 $1.23 7/31/2024111,100 shares $159,428.50 +319.3%0.9%0.9 $1.44 Get the Latest News and Ratings for PMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 7/15/202426,500 shares $56,445.00 +72.1%0.2%3.8 $2.13 6/30/202415,400 shares $23,100.00 +43.9%0.1%1.8 $1.50 6/15/202410,700 shares $17,262.31 +64.6%0.1%1.1 $1.61 5/31/20246,500 shares $11,973.00 -4.4%0.1%0.6 $1.84 5/15/20246,800 shares $12,240.00 -10.5%0.1%0.5 $1.80 4/30/20247,600 shares $15,223.56 -67.1%0.1%0.5 $2.00 4/15/202423,100 shares $50,127.00 -2.9%0.2%1.2 $2.17 3/31/202423,800 shares $45,458.00 -0.8%0.2%0.6 $1.91 3/15/202424,000 shares $45,840.00 +21.8%0.4%0.5 $1.91 2/29/202419,700 shares $41,173.00 +7.1%0.3%0.4 $2.09 2/15/202418,400 shares $35,880.00 -33.1%0.3%0.4 $1.95 1/31/202427,500 shares $55,000.00 No Change0.4%0.6 $2.00 6/15/2023200 shares $984.00 -33.3%N/A0.1 $4.92 5/31/2023300 shares $1,467.39 No ChangeN/A0.1 $4.89 5/15/2023300 shares $1,764.00 No ChangeN/A0.1 $5.88 PMN Short Interest - Frequently Asked Questions What is ProMIS Neurosciences' current short interest? Short interest is the volume of ProMIS Neurosciences shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 137,800 shares of PMN short. 0.60% of ProMIS Neurosciences' shares are currently sold short. Learn More on ProMIS Neurosciences' current short interest. What is a good short interest ratio for ProMIS Neurosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMN shares currently have a short interest ratio of 1.0. Learn More on ProMIS Neurosciences's short interest ratio. What is a good short interest percentage for ProMIS Neurosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.60% of ProMIS Neurosciences' floating shares are currently sold short. Is ProMIS Neurosciences' short interest increasing or decreasing? ProMIS Neurosciences saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 137,800 shares, an increase of 7.7% from the previous total of 128,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ProMIS Neurosciences' float size? ProMIS Neurosciences currently has issued a total of 29,885,000 shares. Some of ProMIS Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ProMIS Neurosciences currently has a public float of 23,040,000 shares. How does ProMIS Neurosciences' short interest compare to its competitors? 0.60% of ProMIS Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ProMIS Neurosciences: CytomX Therapeutics, Inc. (7.77%), Milestone Pharmaceuticals Inc. (0.84%), Metagenomi, Inc. (1.99%), Adlai Nortye Ltd. (0.01%), Cellectar Biosciences, Inc. (5.65%), ALX Oncology Holdings Inc. (31.74%), Verrica Pharmaceuticals Inc. (17.38%), Spero Therapeutics, Inc. (0.72%), Citius Pharmaceuticals, Inc. (6.87%), RAPT Therapeutics, Inc. (8.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short ProMIS Neurosciences stock? Short selling PMN is an investing strategy that aims to generate trading profit from ProMIS Neurosciences as its price is falling. PMN shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProMIS Neurosciences? A short squeeze for ProMIS Neurosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMN, which in turn drives the price of the stock up even further. How often is ProMIS Neurosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMN, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies CTMX Short Interest Data MIST Short Interest Data MGX Short Interest Data ANL Short Interest Data CLRB Short Interest Data ALXO Short Interest Data VRCA Short Interest Data SPRO Short Interest Data CTXR Short Interest Data RAPT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.